Affymax Company Profile (OTCMKTS:AFFY)

About Affymax (OTCMKTS:AFFY)

Affymax logoAffymax, Inc. is a biopharmaceutical company. The Company's product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The Company has a collaboration to develop and commercialize peginesatide with Takeda Pharmaceutical Company Limited. In March 2012, the Food and Drug Administration (FDA) approved the Company's product, OMONTYS.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Symbol: OTCMKTS:AFFY
  • CUSIP: 00826A10
  • Web:
  • Market Cap: $1.69 million
  • Outstanding Shares: 37,490,000
Average Prices:
  • 50 Day Moving Avg: $0.05
  • 200 Day Moving Avg: $0.05
  • 52 Week Range: $0.05 - $0.10
  • Trailing P/E Ratio: 0.549
  • Foreward P/E Ratio: -0.06
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: $41,999.00
  • Price / Sales: 40.17
  • Book Value: $0.14 per share
  • Price / Book: 0.33
  • EBIDTA: ($47,650,000.00)
  • Average Volume: 14,416 shs.
  • Beta: 2.04
  • Short Ratio: 2.35
Frequently Asked Questions for Affymax (OTCMKTS:AFFY)

What is Affymax's stock symbol?

Affymax trades on the OTCMKTS under the ticker symbol "AFFY."

Who are some of Affymax's key competitors?

Who are Affymax's key executives?

Affymax's management team includes the folowing people:

  • John A. Orwin, Independent Chairman of the Board
  • Jonathan M. Couchman, President, Chief Executive Officer, Director
  • Mark G. Thompson, Chief Financial Officer
  • Grace U. Shin J.D., General Counsel

How do I buy Affymax stock?

Shares of Affymax can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Affymax's stock price today?

One share of Affymax stock can currently be purchased for approximately $0.05.

MarketBeat Community Rating for Affymax (OTCMKTS AFFY)
Community Ranking:  3.6 out of 5 (  )
Outperform Votes:  94 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  132
MarketBeat's community ratings are surveys of what our community members think about Affymax and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Affymax (OTCMKTS:AFFY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Affymax (OTCMKTS:AFFY)
No equities research coverage for this company has been tracked by


Earnings History for Affymax (OTCMKTS:AFFY)
Earnings by Quarter for Affymax (OTCMKTS:AFFY)
Earnings History by Quarter for Affymax (OTCMKTS AFFY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2013Q113($0.66)($0.71)$63.20 million$0.84 millionViewN/AView Earnings Details
4/2/2013Q4 2012($0.61)($1.85)$14.81 million$14.77 millionViewN/AView Earnings Details
11/8/2012Q312($0.70)($0.68)$13.41 million$13.60 millionViewN/AView Earnings Details
8/8/2012($0.67)($0.89)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Affymax (OTCMKTS:AFFY)
Current Year EPS Consensus Estimate: $-0.970 EPS
Next Year EPS Consensus Estimate: $-0.700 EPS


Dividend History for Affymax (OTCMKTS:AFFY)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Affymax (OTCMKTS:AFFY)
Insider Ownership Percentage: 1.55%
Insider Trades by Quarter for Affymax (OTCMKTS:AFFY)
Insider Trades by Quarter for Affymax (OTCMKTS:AFFY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/28/2013John Peter WalkerDirectorSell16,540$1.92$31,756.80View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Affymax (OTCMKTS:AFFY)
Latest Headlines for Affymax (OTCMKTS:AFFY)
DateHeadline logoJohn A. Orwin Joins Retrophin Board of Directors - March 23 at 6:48 PM logoIs It Time to Buy Illumina Inc. Stock? - March 14 at 11:39 AM



Affymax (AFFY) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by Staff